Our elected officials may be called upon to do double-duty to protect us against what the federal government may do during ...

Get key insights from AptarGroup’s Q3 2025 earnings call—injectables growth, Brazil expansion, and 2026 margin headwinds. See what’s next for ATR.

The rise of infections caused by Mgen, C. auris, treatment-resistant E. coli, and more could become future public-health ...

Obesity is a modifiable risk factor for a number of conditions, including inflammatory and malignant lung disease, and is now ...

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic ...

RedChip Companies will host an investor webinar with Connect Biopharma Holdings Limited (Nasdaq:CNTB) (Connect Biopharma, ...

Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular ...

Medication treatment for COPD usually involves inhaled medications, such as beta agonists like albuterol or long-acting forms ...

A new injectable medicine is giving hope to people with asthma by helping them breathe better. The drug, called dupilumab ...

Researchers at Guangzhou Laboratory and Guangzhou Medical University have described compounds reported to be useful for the treatment of asthma, bronchitis, chronic obstructive pulmonary disease (COPD ...

An anti-inflammation injectable drug called dupilumab can reduce mucus buildup and improve breathing among asthma patients, a ...